-
STAT News – Biotech6 months agoSTAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos
Good morning. I’ve been seeing posts everywhere about a group of dogs, led by a corgi, that reportedly escaped captivity and traveled across highways to get...
-
STAT News – Biotech6 months agoSTAT+: Pharmalittle: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the blustery Pharmalot campus,...
-
STAT News – Biotech6 months agoAre we underestimating alcohol-related liver disease?
Good morning. With so much snow this winter, I gave up on biking to the office for a while. I’m happy to be back at it...
-
STAT News – Biotech6 months agoWhat growing up in an end-times church taught a science communicator about dispelling misinformation
Belief systems, turns out, can be like dams. However established, they can’t survive even the smallest crack: slowly, but inexorably, if somehow a small seed of...
-
STAT News – Biotech6 months agoSTAT+: The potential loophole in Trump’s plan to get other countries to pay more for drugs
WASHINGTON — Comments from a top Trump administration health official add to signs of a major flaw in the president’s most-favored nation drug pricing plans. The...
-
STAT News – Biotech6 months agoOpinion: Covid followed 5 standard stages of pandemic response — until it became unprecedented
Six years after the Covid shutdown of March 2020, the nation is still struggling to recover from a trauma that has become deeply politicized. Despite a...
-
STAT News – Biotech6 months agoSTAT+: This bill could make CVS choose between its stores and its pharmacy benefit manager
WOONSOCKET, R.I. — A proposal in the Tennessee legislature could force CVS Health to sever a core piece of its business model or exit the state entirely, and...
-
STAT News – Biotech6 months agoNIH grant terminations affected women scientists more than men, study finds
Academics have long referred to their field as a leaky pipeline — gradually bleeding researchers from marginalized communities as they progress through their careers. A new paper,...
-
STAT News – Biotech6 months agoSTAT+: Pharmalittle: We’re reading about Iran war’s impact on pharma supply chain, a Pfizer Lyme vaccine, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and...
-
STAT News – Biotech6 months agoSTAT+: Pfizer’s Lyme vaccine results set up tricky regulatory path
Pfizer and Valneva’s Lyme disease vaccine cut cases by about 73% in a Phase 3 trial, but missed its primary statistical endpoint — setting up a...
Considerations for Potential Future Therapeutic Use of Psychedelic Drugs Public Hearing – 09/14/2026
Takeda’s Plump, GV’s Yeshwant announce retirement plans
STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
